Hims Hers Health

Yahoo Finance • 6 days ago

2 Top Stocks to Buy With $500 Right Now

Key Points Amazon's cost-cutting could supercharge its profitability. Hims & Hers has explosive long-term growth potential. 10 stocks we like better than Amazon › We're coming to the close of 2025, and it has been an excellent year for s... Full story

Yahoo Finance • 15 days ago

Hims stock falls after lawmakers propose GLP-1 compounding restrictions

Investing.com -- Hims Hers Health Inc (NYSE:HIMS) stock fell 4.4% Wednesday after U.S. lawmakers introduced legislation that could significantly impact the company’s fastest-growing product category. The bipartisan "Safeguarding Americans... Full story

Yahoo Finance • 17 days ago

From Hype to P&L: Hospitals Now Buying AI That Pays

VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) --  USANewsGroup.comNews Commentary – Hospitals running on thin margins are done chasing clinical moonshots[1]. They want AI that improves the bottom line. Healthcare AI spendin... Full story

Yahoo Finance • 21 days ago

Hims & Hers Health, Inc. (HIMS): A Bull Case Theory

We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc.'s share was trading at $39.76... Full story

Yahoo Finance • 21 days ago

The Three Moves Hims & Hers Made This Week To Bolster Its Weight-Loss Biz

Hims & Hers Health announced its expansion into Canada on Thursday, sending Hims stock higher in early action. Continue Reading... Full story

Yahoo Finance • 23 days ago

Hims & Hers Health (HIMS): Evaluating Valuation After Recent Share Price Drop

Hims & Hers Health (HIMS) is attracting attention as investors size up its performance after recent share price movement. Over the past month, shares have fallen 17%, prompting questions about underlying fundamentals and future prospects.... Full story

Yahoo Finance • 28 days ago

Guru Fundamental Report for HIMS - Benjamin Graham

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value metho... Full story

Yahoo Finance • last month

Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1

[Novo Nordisk office in Fremont, California, USA] JHVEPhoto/iStock Editorial via Getty Images Lilly’s (LLY [https://seekingalpha.com/symbol/LLY]) recent climb to reach a $1T market cap will come under scrutiny in the coming days when Novo... Full story

Yahoo Finance • last month

Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4.9% in the afternoon session after news of increased competition in the weight-loss drug market overshadowed the company’s own positive announcements. The s... Full story

Yahoo Finance • last month

Hims & Hers health authorizes $250 million share repurchase program

* Hims & Hers Health (HIMS [https://seekingalpha.com/symbol/HIMS]) has authorized a share repurchase program of up to $250 million of outstanding Class A common stock over the next three years, the company said on Monday. * This new pr... Full story

Yahoo Finance • last month

Novo Nordisk cuts Wegovy, Ozempic direct-to-user prices to match Eli Lilly’s Zepbound

[Woman administering an injection at home for health and medical treatment] Milko Novo Nordisk (NVO [https://seekingalpha.com/symbol/NVO]) is cutting prices to challenge rival Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) in the o... Full story

Yahoo Finance • last month

Family Alleges Hims & Hers Health, Inc.’s Rush Into Mental Healthcare Violated Washington Law and Resulted in Son’s Death

SEATTLE, Nov. 14, 2025 (GLOBE NEWSWIRE) -- This week, the parents of Luke Tyler, the Washington State University (WSU) freshman who was found dead in his dorm room on January 22, 2023, filed a wrongful death lawsuit in the King County Su... Full story

Yahoo Finance • last month

2 Strong Healthcare Stock Picks for Growth Investors

Key Points The health industry offers opportunities beyond the big, well-known names. TransMedics Group boasts a sticky business model that is highly profitable. Hims & Hers is expanding its core offerings and moving into new markets. 10... Full story

Yahoo Finance • last month

Validea Detailed Fundamental Analysis - HIMS

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy... Full story

Yahoo Finance • 2 months ago

Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?

Key Points Hims & Hers continues to generate strong revenue growth. The company said it was in active discussion with Novo Nordisk to bring back Wegovy to its platform. The stock looks attractively priced at current levels, given its gro... Full story

Yahoo Finance • 2 months ago

Analysts Anticipate 11% Gains Ahead For The Holdings of PDP

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 2 months ago

Earnings live: Pinterest stock tanks, AMD and Supermicro falter, Rivian pops amid flurry of Q3 reports

The third quarter earnings season is in full swing, with several AI players reporting results this week, including Palantir (PLTR), AMD (AMD), and Supermicro (SMCI). So far, the earnings season is off to a positive start. As of Oct. 31, 6... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Clorox and more

Check out the companies making headlines in after-hours trading. Palantir Technologies — Shares of Palantir rose 1% in extended trading after the software company reported quarterly results that beat Wall Street's estimates , with governme... Full story

Yahoo Finance • 2 months ago

Why Pfizer Can Still Prevail in the Obesity Fight With Novo Nordisk

Novo Nordisk and Pfizer are showing some desperation in their gloves-off tussle for the obesity-drug assets of Metsera. Continue Reading Afficher les commentaires... Full story

Yahoo Finance • 2 months ago

LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc.

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- A securities fraud class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS) is pending. The lawsuit was filed by Glancy Prongay & Murray LLP. Previous press releases stated incorrectl... Full story